Want to see HK:3332 full AI Analyst Report?
Nanjing Sinolife United Co., Ltd. Class H (3332) Price & Analysis
3332 Stock Chart & Stats
- Day’s Range
- HKD 0.14 - HKD 0.17
- 52-Week Range
- HKD 0.08 - HKD 0.47
- Previous Close
- HKD 0.16
- Volume
- 70.00K
- Average Volume (3M)
- 87.67K
- Market Cap
- HKD 246.26M
- Enterprise Value
- HKD 33.31M
- Total Cash (Recent Filing)
- HKD 309.78M
- Total Debt (Recent Filing)
- HKD 191.24M
- Price to Earnings (P/E)
- 6.3
- Beta
- -0.23
- Next Earnings
- Mar 31, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Revenue expansion across 2020–2025 indicates that the company has increased its business scale over multiple years rather than relying solely on a brief surge. Continued top-line growth can support operating investment, broaden earnings potential, and strengthen its position over the next several quarters.
Strong Gross Margin
A gross margin of about 73% provides substantial revenue retained after direct costs, creating economic room to fund operations, product development, and commercial activity. The multi-year improvement also suggests a durable gross-profit foundation, even though downstream profitability remains pressured.
Equity Base And Moderate Leverage
The sizable equity base relative to total assets gives the company a meaningful balance-sheet buffer and supports financial stability. Debt-to-equity remains moderate at roughly 0.26, leaving more flexibility to absorb operating volatility and fund priorities than a highly leveraged structure would allow.
Bears Say
Margin Compression
The sharp decline in net margin shows that revenue growth is translating into substantially less bottom-line profit than at the 2023 peak. Unless operating costs or heavier spending are brought under control, weaker earnings conversion could constrain reinvestment and reduce the durability of returns.
Volatile Cash Generation
The strong 2025 cash-flow rebound is encouraging, but negative free cash flow in multiple periods demonstrates that cash generation has not been consistently aligned with reported profitability. This variability can complicate planning, capital allocation, and the company’s ability to self-fund growth reliably.
Rising Debt-Funded Posture
The increase in debt-to-equity indicates a more debt-funded balance-sheet posture than in prior years, while the lower ROE points to reduced earnings efficiency. Together, these trends may limit financial flexibility and make future returns more dependent on restoring profitability.
Nanjing Sinolife United Co., Ltd. Class H News
3332 FAQ
What was Nanjing Sinolife United Co., Ltd. Class H’s price range in the past 12 months?
What is Nanjing Sinolife United Co., Ltd. Class H’s market cap?
When is Nanjing Sinolife United Co., Ltd. Class H’s upcoming earnings report date?
How were Nanjing Sinolife United Co., Ltd. Class H’s earnings last quarter?
Is Nanjing Sinolife United Co., Ltd. Class H overvalued?
Does Nanjing Sinolife United Co., Ltd. Class H pay dividends?
What is Nanjing Sinolife United Co., Ltd. Class H’s EPS estimate?
How many shares outstanding does Nanjing Sinolife United Co., Ltd. Class H have?
What happened to Nanjing Sinolife United Co., Ltd. Class H’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Nanjing Sinolife United Co., Ltd. Class H?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nanjing Sinolife United Co., Ltd. Class H
Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia, New Zealand, Vietnam, and various international markets. The firm additionally produces and markets cosmetics and skincare items, while also undertaking the trading, retail, and testing of pre-packaged health food products. Products are sold under well-known brands such as Good Health, Zhongsheng, Hejian, and Cobayer, primarily via its comprehensive network of retail outlets. Distribution also encompasses sales through distributors, television shopping channels, online e-commerce platforms, chain pharmacies, specialized health food supermarkets, and tourist souvenir shops. The company, which has been headquartered in Nanjing, China, since its establishment in 1999.
- Sector
- Consumerdefensive
- Industry
- Medical - Pharmaceuticals
- CEO
- Yuan Zhang
- Employees
- 533
- Website
- www.zs-united.com
- Address
- CN
Nanjing Sinolife United Co., Ltd. Class H (3332) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |